Genzyme Corp. et al v. Cipla Limited > Summary
Court Case Number 1:18-cv-01838
Filing Date Nov 20, 2018
Termination Date Oct 8, 2019
Court Delaware District Court
Status Dismissed - Settled
JudgesColm F. Connolly
Defendant
Plaintiff Attorneys
12Sanofi
Attorney Name: Katherine E. Adams
Venable
Sanofi
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Sanofi
Attorney Name: Damien N. Dombrowski
Venable
Sanofi
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
Sanofi
Attorney Name: Daniel J. Minion
Venable
The Regents Of The University Of Michigan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
The Regents Of The University Of Michigan
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
The Regents Of The University Of Michigan
Attorney Name: Daniel J. Minion
Venable
Sanofi
Attorney Name: William E. Solander
Venable
Sanofi
Attorney Name: Michael E. Furrow
Venable
University Of Michigan
Attorney Name: William E. Solander
Venable
University Of Michigan
Attorney Name: Michael E. Furrow
Venable
Defendant Attorneys
4Cipla limited
Attorney Name: Jitendra Malik
Katten Muchin Rosenman
Cipla limited
Attorney Name: Alissa Marie Pacchioli
Katten Muchin Rosenman
Cipla limited
Attorney Name: John C. Phillips Jr.
Phillips, McLaughlin & Hall, P.A.
Counter Defendant
4Sanofi
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Counter Claimant
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07615573 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | Nov 10, 2009 |
| 07253185 | Amino ceramide-like compounds and therapeutic methods of use | Aug 7, 2007 |
| 07196205 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | Mar 27, 2007 |
| 06916802 | Amino ceramide-like compounds and therapeutic methods of use | Jul 12, 2005 |
